Showing results (1-10 of 187) with videos related to
Sort By:
Pageof 19
Seminars in Pediatric Neurology|December 5, 2003
Ataxia-telangiectasia: diagnosis and treatmentSusan Perlman, Sara Becker-Catania, Richard A GattiHandbook of Clinical Neurology|February 27, 2018
Von Hippel-Lindau disease and Sturge-Weber syndromeSusan PerlmanAnnals of the New York Academy of Sciences|February 28, 2012
SMRT compounds correct nonsense mutations in primary immunodeficiency and other genetic modelsRichard A GattiNature Communications|May 9, 2013
SMRT compounds abrogate cellular phenotypes of ataxia telangiectasia in neural derivatives of patient-specific hiPSCsPeiyee Lee, Nathan T Martin, Kotoka Nakamura, et al.Journal of Molecular Cell Biology|December 25, 2010
MicroRNAs: new players in the DNA damage responseHailiang Hu, Richard A GattiJournal of Immunological Methods|December 15, 2010
Potential therapeutic applications of antisense morpholino oligonucleotides in modulation of splicing in primary immunodeficiency diseasesLiutao Du, Richard A GattiCurrent Opinion in Molecular Therapeutics|March 31, 2009
Progress toward therapy with antisense-mediated splicing modulationLiutao Du, Richard A GattiBlood|February 27, 2013
Pathogenesis of ataxia-telangiectasia: the next generation of ATM functionsMark Ambrose, Richard A GattiCurrent Opinion in Allergy and Clinical Immunology|November 4, 2008
New approaches to treatment of primary immunodeficiencies: fixing mutations with chemicalsHailiang Hu, Richard A GattiPageof 19